About this Research Topic
The drive for the new generation of vaccine therapies has precipitated a concurrent need for new and improved adjuvantation and delivery systems for these new vaccines. The article collection around this new international conference will focus on updating the community on new adjuvant, delivery systems and technologies associated with developing modern vaccine strategies and vaccine research. There is now an urgent need for the development of these potent and safe adjuvants and delivery systems and the MVADS 2023 conference, as well as this Research Topic, will offer researchers a fresh forum to discuss this important subject in detail.
This Research Topic will be of interest to the MVADS 2023 conference attendees, researchers, contributors from academic programs, and industrial, governmental, and regulatory groups.
The goals of this article collection are:
- to bring together international experts from the vaccine delivery field for the purpose of exchanging new ideas and brainstorming novel solutions to existing field challenges
- to highlight new methods and technologies in developing modern vaccines and adjuvants
This Research Topic aims to collect original research, reviews, mini-reviews, and perspective articles on late-breaking developments and new research directions from the field of Vaccine Delivery.
Topic editor Dennis Christensen is employed by Croda (Denmark).
The Topic Editor Camilla Foged declares no competing interests with regard to the Research Topic subject.
Keywords: vaccine delivery, modern vaccines, adjuvants, novel delivery systems, MVADS 2023
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.